Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
Valneva SE

Start price
Target price
Perf. (%)
€8.01
05.09.22
-
05.10.26
-57.57%
11.03.24

Probably not worthwhile Investment
Cellectis Nom.

Start price
Target price
Perf. (%)
€1.26
16.10.23
-
16.10.24
95.87%
19.01.24

Risky Investment
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€1.51
27.11.23
-
27.11.24
4.25%
11.12.23

Probably not worthwhile Investment
buy
Adocia

Start price
Target price
Perf. (%)
€8.54
02.10.23
-
02.10.24
-3.28%
10.12.23

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.10
01.11.23
€2.50
01.11.24
-25.24%
09.12.23

Could be worthwhile Investment >10% per year
Adocia

Start price
Target price
Perf. (%)
€8.39
25.11.23
€4.00
25.11.24
-1.55%
09.12.23

Probably not worthwhile Investment
High valuation
Little Investments for future growth
Below average Management
Cellectis Nom.

Start price
Target price
Perf. (%)
€1.96
01.11.23
€1.00
01.11.24
20.31%
11.11.23

Good culture
Below average Management
Few uniques
Probably not worthwhile Investment
Cellectis Nom.

Start price
Target price
Perf. (%)
€2.39
01.11.23
-
01.11.24
-1.42%
10.11.23

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.81
24.12.22
-
24.12.23
-25.37%
01.11.23

Could be worthwhile Investment >10% per year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€6.02
27.10.22
-
27.10.23
-42.03%
28.10.23

Could be worthwhile Investment >10% per year
Carmat

Start price
Target price
Perf. (%)
€12.25
22.10.22
€10.00
22.10.23
-72.94%
23.10.23

Could be worthwhile Investment >10% per year
Adocia

Start price
Target price
Perf. (%)
€9.86
16.09.23
€4.00
16.09.24
-22.11%
30.09.23

Probably not worthwhile Investment
High valuation
Little Investments for future growth
Below average Management
buy
Cellectis Nom.

Start price
Target price
Perf. (%)
€3.52
07.08.22
€3.80
07.08.23
-52.13%
08.08.23

Could be worthwhile Investment >10% per year
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€9.10
04.08.22
-
04.08.23
81.32%
05.08.23

Could be very worthwhile Investment >20% year
Valneva SE

Start price
Target price
Perf. (%)
€9.82
21.07.22
-
21.07.23
-30.16%
22.07.23

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€2.49
20.08.22
-
20.08.23
-75.54%
07.06.23

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€10.23
09.08.22
€14.00
09.08.23
-46.91%
30.05.23

Small cyclical dependencies
Below average Marketposition
Few uniques
Abivax S.A.

Start price
Target price
Perf. (%)
€8.30
02.09.22
€5.00
31.12.24
85.30%
08.05.23

Could be very worthwhile Investment >20% year
Innate Pharma

Start price
Target price
Perf. (%)
€2.51
07.03.22
-
07.03.23
21.39%
08.03.23

Probably not worthwhile Investment
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.24
10.02.22
€3.80
10.02.23
-4.81%
11.02.23

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.03
05.02.22
€20.00
05.02.23
-57.41%
06.02.23

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€1.11
01.02.23
-
01.02.24
-0.36%
05.02.23

Risky Investment
buy
Quantum Genomics S.A.

Start price
Target price
Perf. (%)
€4.32
31.12.21
€5.00
31.12.22
-97.78%
01.01.23

Could be worthwhile Investment >10% per year
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€14.28
24.12.22
-
24.12.23
-
24.12.22

Could be worthwhile Investment >10% per year